StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.61+0.02 (+3.06%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Imunon cash

Cash and short-term investments held at the end of each period.

Imunon's cash was $4.80M at Mar 31, 2026. For fiscal 2025 it was $8.80M, up 49.2% from the year before. Over ten years it grew -7.9% a year on average. The highest annual figure on record is $56.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.80M+49.2%
FY2024Dec 31, 2024$5.90M-62.4%
FY2023Dec 31, 2023$15.70M-52.1%
FY2022Dec 31, 2022$32.80M-42.4%
FY2021Dec 31, 2021$56.90M+231.5%
FY2020Dec 31, 2020$17.16M+15.8%
FY2019Dec 31, 2019$14.82M-46.3%
FY2018Dec 31, 2018$27.58M+14.0%
FY2017Dec 31, 2017$24.20M+462.8%
FY2016Dec 31, 2016$4.30M-78.6%
FY2015Dec 31, 2015$20.07M-45.6%
FY2014Dec 31, 2014$36.86M-14.0%
FY2013Dec 31, 2013$42.87M+86.2%
FY2012Dec 31, 2012$23.03M-18.3%
FY2011Dec 31, 2011$28.18M+1736.7%
FY2010Dec 31, 2010$1.53M-77.8%
FY2009Dec 31, 2009$6.92M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$4.80M+65.5%
Q4 FY2025Dec 31, 2025$8.80M+49.2%
Q3 FY2025Sep 30, 2025$5.30M-48.5%
Q2 FY2025Jun 30, 2025$4.70M-11.3%
Q1 FY2025Mar 31, 2025$2.90M-70.4%
Q4 FY2024Dec 31, 2024$5.90M-62.4%
Q3 FY2024Sep 30, 2024$10.30M-47.2%
Q2 FY2024Jun 30, 2024$5.30M-78.0%
Q1 FY2024Mar 31, 2024$9.80M-70.1%
Q4 FY2023Dec 31, 2023$15.70M-58.0%
Q3 FY2023Sep 30, 2023$19.50M-59.5%
Q2 FY2023Jun 30, 2023$24.10M-49.0%
Q4 FY2022Dec 31, 2022$32.80M-42.4%
Q3 FY2022Sep 30, 2022$37.40M-31.4%
Q2 FY2022Jun 30, 2022$48.10M-17.6%
Q1 FY2022Mar 31, 2022$47.30M-10.3%
Q4 FY2021Dec 31, 2021$56.90M+231.5%
Q3 FY2021Sep 30, 2021$54.51M+197.2%
Q2 FY2021Jun 30, 2021$58.36M+129.4%
Q1 FY2021Mar 31, 2021$52.76M+237.5%
Q4 FY2020Dec 31, 2020$17.16M+15.8%
Q3 FY2020Sep 30, 2020$18.34M-2.3%
Q2 FY2020Jun 30, 2020$25.44M+17.7%
Q1 FY2020Mar 31, 2020$15.63M-33.9%
Q4 FY2019Dec 31, 2019$14.82M-46.3%
Q3 FY2019Sep 30, 2019$18.78M-14.4%
Q2 FY2019Jun 30, 2019$21.62M-17.5%
Q1 FY2019Mar 31, 2019$23.66M+14.3%
Q4 FY2018Dec 31, 2018$27.58M+14.0%
Q3 FY2018Sep 30, 2018$21.93M+716.8%
Q2 FY2018Jun 30, 2018$26.20M+622.0%
Q1 FY2018Mar 31, 2018$20.70M+363.1%
Q4 FY2017Dec 31, 2017$24.20M+462.8%
Q3 FY2017Sep 30, 2017$2.69M-69.1%
Q2 FY2017Jun 30, 2017$3.63M-74.9%
Q1 FY2017Mar 31, 2017$4.47M-68.8%
Q4 FY2016Dec 31, 2016$4.30M–
Q3 FY2016Sep 30, 2016$8.70M–
Q2 FY2016Jun 30, 2016$14.47M–
Q1 FY2016Mar 31, 2016$14.31M–

More Imunon figures

See a number that looks wrong?